Page 62 - Annual Report 2018
P. 62

projects), whose main investigators are Drs. Miguel
                                                              Medina and Miguel Calero. The main objective of
                                                              this proposal is to explore the possible role of miRNAs
                                                              and markers of lipid metabolism as possible links bet-
                                                              ween peripheral vascular dysfunction and the pa-
                                                              thophysiology of AD. The design of the project is
                                                              based on a double approach with complementary
                                                              aims related to the existing cohorts (Vallecas Project
                                                              and Research Program of the Vallecas Research
                                                              Center (PICAV) and the CIEN Foundation Brain Bank.
                                                              The central working hypothesis builds upon the exis-
                                                              tence of circulating miRNAs and molecules of lipid
                                                              metabolism in plasma that could differentiate cog-
                                                              nitively normal individuals from people with mild
                                                              cognitive impairment or dementia, either alone or in
                                                              combination with other parameters being collected
                                                              from the same individuals (elderly volunteers) within
                                                              the Vallecas Project, as well as patients with confir-
                                                              med AD after autopsy. To this end, we propose to

                                                               Distribuon of APOE genotypes
                                                               in the CAFRS paents cohort

                                                               APOE genotypes
                                                                                         ε2/ε3
                                                                                   ε2/ε2
                                                                                           19
                                                                                     0     5%    ε2/ε4
                                                                             ε4/ε4  0%             5
                                                                              35                  1%
                                                                              8%




                                                                                               ε3/ε3
                                                                                  ε3/ε4         207
                                                                                  164           48%
                                                                                  38%














          CIEN Foundation Annual Report 2018 / 62
   57   58   59   60   61   62   63   64   65   66   67